Replies to post #762659 on NorthWest Biotherapeutics Inc (NWBO)
04/22/25 12:29 AM
04/22/25 12:50 AM
04/22/25 2:05 AM
04/22/25 2:14 AM
04/22/25 5:59 AM
> 639 — To ask the Secretary of State for Health and Social Care, when he expects the Medicines and Healthcare products Regulatory Agency will make public their decision on licensing the personalised immunotherapy developed to treat the malignant brain tumour glioblastoma, DCVax-L.
> 640 — To ask the Secretary of State for Health and Social Care, whether his Department plans to work with the National Institute for Health and Care Excellence to expedite market access to the personalised immunotherapy developed to treat the malignant brain tumour glioblastoma DCVax-L via the NHS
UK Parliament House of Commons will meet on Wednesday 4/23/2025.
Sarah Owens is a Member of Parliament. Ms. Owens will ask 2 questions about NWBio DCVax-L.
The agenda for this meeting, and the list of questions was published today. Ms. Owens is going to ask the UK Secretary of State for Health and Social Care:
(1) when he expects the MHRA to make public their decision on approving & licensing DCVax-L,
(2) does the Secretary plan to work with NICE to expedite market access to DCVax-L, via the NHS?
| Volume | |
| Day Range: | |
| Bid Price | |
| Ask Price | |
| Last Trade Time: |